Literature DB >> 11727773

Substance P receptor mediated macrophage responses.

I Marriott1, K L Bost.   

Abstract

Taken together, these studies demonstrate an important role for substance P receptor expression by macrophages. The results to date suggest proinflammatory signals mediated by this receptor, and it is clear that substance P can act synergistically with other factors to stimulate macrophage activity. Antagonism of substance P/substance P receptor interactions in vivo profoundly affect immunity against Salmonella. This model provides evidence that an optimal host response against this intracellular pathogen of macrophages requires signaling through the substance P receptor. The ability of interferon gamma or IL-4 to upregulate substance P receptor mRNA expression on macrophages suggests that substance P-mediated amplification loops might involve either T helper type 1 or T helper type 2 responses. Thus, depending upon the immunologic stimulus, substance P could contribute to cell mediated as well as humoral immune responses. Several important questions remain. Since the antigen processing and presenting function is an important macrophage activity, the effect of signaling through the substance P receptor on these events has not been defined. Furthermore, since macrophages are only one type of antigen presenting cell, it will be important to determine the role of substance P receptor expression in the activity of dendritic cells. We anticipate that these ongoing investigations will further define the positive contributions that substance P/substance P receptor interactions have in the initiation of immune responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727773     DOI: 10.1007/0-306-47611-8_30

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi.

Authors:  Vinita S Chauhan; David G Sterka; David L Gray; Kenneth L Bost; Ian Marriott
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

3.  Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis.

Authors:  Vinita S Chauhan; John M Kluttz; Kenneth L Bost; Ian Marriott
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

Review 4.  Inflammation in acute CNS injury: a focus on the role of substance P.

Authors:  F Corrigan; R Vink; R J Turner
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

Review 5.  Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease.

Authors:  Claudio Bernardazzi; Beatriz Pêgo; Heitor Siffert P de Souza
Journal:  Mediators Inflamm       Date:  2016-07-04       Impact factor: 4.711

6.  Effect of Corneal Nerve Ablation on Immune Tolerance Induced by Corneal Allografts, Oral Immunization, or Anterior Chamber Injection of Antigens.

Authors:  Juan Mo; Sudha Neelam; Jessamee Mellon; Joseph R Brown; Jerry Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

Review 7.  Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation.

Authors:  Frances Corrigan; Kimberley A Mander; Anna V Leonard; Robert Vink
Journal:  J Neuroinflammation       Date:  2016-10-11       Impact factor: 8.322

Review 8.  The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders.

Authors:  M Brittany Johnson; Ada D Young; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2017-01-04       Impact factor: 5.505

Review 9.  Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections?

Authors:  Surendran Mahalingam; Jurgen Schwarze; Ali Zaid; Michael Nissen; Theo Sloots; Sharyn Tauro; James Storer; Rene Alvarez; Ralph A Tripp
Journal:  Microbes Infect       Date:  2005-08-10       Impact factor: 2.700

10.  The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.

Authors:  Aristo Vojdani; Jama Lambert
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.